Nimustine hydrochloride: the first crystal structure determination of a 2‐chloroethyl‐N‐nitrosourea hydrochloride derivative by X‐ray powder diffraction and solid‐state NMR

Nimustine hydrochloride [systematic name: 4‐amino‐5‐({[N‐(2‐chloroethyl)‐N‐nitrosocarbamoyl]amino}methyl)‐2‐methylpyrimidin‐1‐ium chloride], C₉H₁₄ClN₆O₂⁺·Cl⁻, is a prodrug of CENU (chloroethylnitrosourea) and is used as a cytostatic agent in cancer therapy. Its crystal structure was determined from laboratory X‐ray powder diffraction data. The protonation at an N atom of the pyrimidine ring was established by solid‐state NMR spectroscopy.